From Evidence to Practice: How VI-RADS is transforming Bladder Cancer MRIJuly 4, 2025 Introduction Bladder cancer is one of the most common malignancies worldwide. Accurate local tumor […] Read More
What’s new in Genitourinary Imaging – June 2021June 1, 2021 Original Research Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral […] Read More
What’s new in Genitourinary Imaging – April 2021March 31, 2021 Original Research Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography The […] Read More
What’s new in Genitourinary Imaging – February 2021January 31, 2021 Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition […] Read More
What’s new in Genitourinary Imaging – December 2020November 30, 2020 MRI-based Bosniak Classification of Cystic Renal Masses, Version 2019: Interobserver Agreement, Impact of Readers’ […] Read More
What’s new in Genitourinary Imaging – September 2020September 1, 2020 Novel T2 Mapping for Evaluating Cervical Cancer Features by Providing Quantitative T2 Maps and […] Read More
What’s new in Genitourinary Imaging – August 2020August 1, 2020Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI Lindenberg […] Read More
What’s new in Genitourinary Imaging – July 2020July 3, 2020In this blog, we provide a synopsis of the latest in Genitourinary Imaging published during […] Read More